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The malaria parasite carries a plastid called the api-
coplast that has been the subject of intense study in 
the last 15 years. Having originated from red-algal 
plastids, the apicoplast has lost its ability to photo-
synthesize, but carries out other essential functions 
such as type-II fatty acid synthesis, biosynthesis of 
haem and isoprenoid synthesis; the DOXP pathway 
for isoprenoid synthesis has recently been demon-
strated to be the only pathway critical for parasite 
survival in the erythrocytic stage. The apicoplast also 
has a functional Suf system for assembly of (Fe–S) 
complexes on target proteins. The organelle has  
a 35 kb, double-stranded DNA genome that encodes a 
set of RNAs and proteins, the latter being translated 
from organellar mRNA by an active translation  
machinery, a major component of which is encoded by 
the nucleus. This article reviews current knowledge of 
housekeeping functions of the Plasmodium apicoplast 
and its (Fe–S) assembly system and discusses these 
components as sites for drug intervention against  
malaria. 
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Introduction 
THE malaria parasite and most of its protist cousins in the 
group Apicomplexa contain a non-photosynthetic relic 
plastid called the apicoplast. The organelle was discov-
ered in the mid to late 1990s by Wilson and colleagues, 
who first identified a genome distinct from the Plasmo-
dium mitochondrial DNA1. The sequence of this 35 kb 
circular DNA molecule revealed its close resemblance to 
plastid genomes and the molecule was subsequently  
localized to a distinct organelle by in situ hybridization2. 
Labelling by a fluorescent apicoplast targeted protein  
revealed the changing morphology of the apicoplast in 
the blood stages of the Plasmodium falciparum life  
cycle3. The apicoplast exists in close proximity to the  
mitochondrion of Plasmodium and attains an intricate 
branched structure in the trophozoite stage. Upon
schizogony, each daughter merozoite gets a single api-
coplast. The organelle is seen in all stages of the Plasmo-
dium cycle and is maternally inherited4. 
 The apicoplast is enclosed by four membranes,  
suggesting its origin as a secondary endosymbiont. It is 
now believed that the organelle originated from two  
endosymbiotic events, the first involving a cyanobacte-
rium-like prokaryote and a primary host, and the second 
involving an endosymbiotic alga and a eukaryotic host. 
Despite early disagreements over the green or red algal 
lineage of the second endosymbiont, there is emerging 
consensus that it was the latter5. This view has been 
strengthened by the discovery of the photosynthetic, free-
living apicomplexan Chromera velia, which clearly has a 
plastid derived from red alga6. 
 The genome of the apicoplast is much reduced in com-
parison with other plastid genomes and primarily encodes 
components for transcription and translation1,7. There are 
also ORFs that encode a predicted Ycf24/SufB protein of 
the (Fe–S) complexation pathway and a Clp protease1. 
The apicoplast is essential to the parasite and inhibition 
of its housekeeping functions causes parasite death8. As 
its own coding capacity is limited, the organelle imports 
an array of nuclear-encoded proteins that participate in 
important metabolic pathways that include type-II fatty 
acid biosynthesis3,9, non-mevalonate pathway of isopre-
noid biosynthesis10 and the synthesis of haem11,12. Pro-
teins transported to the apicoplast require a bipartite leader 
sequence carrying an N-terminal signal and transit  
peptide, which can be identified by a set of rules13. This 
has helped predict an apicoplast proteome for identifica-
tion of pathways operative in the organelle14. 
 The requirement of a functional apicoplast for parasite 
survival as well as the cyanobacterial origin and conse-
quent existence of unique pathways and proteins in the 
organelle have identified it as an attractive target for anti-
malarial drug intervention. However, several important 
functions and pathways of the organelle are only partly 
understood. This article presents an overview of the cur-
rent knowledge of mechanisms of DNA replication and 
translation in the apicoplast, discusses the Suf system of 
(Fe–S) cluster biogenesis in the organelle, and briefly re-
views the status of the apicoplast as a target for anti-
malarials. 
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Apicoplast genome organization and  
replication 
Each Plasmodium carries a single apicoplast with esti-
mates of apicoplast DNA (plDNA) copy number varying 
from 1 to 15. The ~ 35 kb double-stranded plDNA mole-
cule has an A + T content of ~ 86% (ref. 1). A single 
plDNA circle is ~ 12 μm in circumference and several 
molecules have to be packed into an organelle with a  
diameter of only ~ 0.3 μm (ref. 15). plDNA also has to 
replicate and divide into daughter molecules without get-
ting tangled. This would require the involvement of a 
DNA-compacting protein in plDNA organization. The  
P. falciparum nuclear-encoded bacterial histone-like  
protein (Pf HU) has been identified as the major DNA  
organization protein in the organelle16,17. A gene encod-
ing a HU-ortholog that carries a conserved BHL domain 
(bacterial histone-like domain) together with a predicted 
N-terminal apicoplast targeting sequence was identified 
on Chr 9 of the P. falciparum nuclear genome. HU pro-
teins are small basic proteins of prokaryotic origin that 
are structurally distinct from eukaryotic histones, belong 
to the DNABII family of DNA-binding proteins, and ex-
hibit hetero- or homo-dimeric DNA binding. HU proteins 
also have regulatory effects on DNA replication, recom-
bination and transcription. Pf HU is expressed throughout 
the intra-erythrocytic phase of parasite growth, exhibits 
DNA binding and is capable of condensing DNA. The 
protein has a unique 42aa C-terminal domain which in-
fluences its interaction with the DNA16. In contrast to 
bacterial HUs that bend DNA, Pf HU promotes concate-
nation of linear DNA and inhibits DNA circularization16. 
Atomic force microscopic study of Pf HU–DNA com-
plexes shows protein concentration-dependent DNA stiff-
ening, intermolecular bundling and formation of DNA 
bridges followed by assembly of condensed DNA net-
works16. The bundling of two strands is likely to be medi-
ated by the interaction between two Pf HU dimers, each 
of which binds to a single DNA strand; the formation of 
such tetrameric Pf HU forms is indicated by chemical 
cross-linking of the protein in solution. Further, the clus-
tering of long DNA bundles and bridges to form large 
complexes at high Pf HU concentration could be medi-
ated by intermolecular interactions between Pf HU 
tetramers. The presence of a functional HU-like protein 
in apicomplexan plastids provides further support for red 
algal ancestry of the apicoplast; the sequence of Pf HU is 
closest to red algal plastid HUs of Cyanidioschizon mer-
olae and Guillardia theta, and the apicomplexan and red 
algal HUs cluster with HU proteins of cyanobacteria. The 
presence of a nuclear gene encoding a HU protein carry-
ing the bipartite signal sequence for apicoplast targeting 
in the malaria parasite indicates that the gene was ac-
quired by a secondary endosymbiotic event from a red 
alga with subsequent transfer from the red algal plastid to 
the host nuclear genome. 
 Although there is extensive sequence similarity be-
tween plDNA of P. falciparum and the related apicom-
plexan, Toxoplasma gondii, the two molecules have 
distinct in vivo topology. The former is circular while the 
latter occurs as an oligomeric series of linear tandem ar-
rays of the 35 kb genome. plDNA of T. gondii replicates 
via the rolling circle mode18, while the major replication 
mode for P. falciparum plDNA is via D-loop/bi-
directional ori19,20. plDNA replication proceeds at the late 
trophozoite–early schizont stage of the intraerythrocytic 
cycle, and origins of replication (plDNA ori) have been 
localized within the inverted repeat (IR) region of the 
plDNA molecule19,20. The IR region of plDNA comprises 
genes for small and large subunit rRNAs and some 
tRNAs. Multiple initiation sites have been identified 
within each IR sector, with initiation occurring with dif-
ferent frequencies during the replication cycle21. 
 The apicoplast genome lacks genes encoding a protein 
for DNA replication. Thus, all major protein components 
involved in plDNA replication must be nuclear-encoded 
and transported to the organelle. Some components of the 
plDNA replication machinery have been identified. A 
~ 220 kDa multi-domain polypeptide (Pf PREX) that con-
tains DNA polymerase as well as DNA primase, DNA 
helicase and 3′–5′ exonuclease activities has been pro-
posed as a key enzyme for plDNA replication22. The ki-
netic parameters and fidelity of the DNA polymerase 
domain of Pf PREX have been reported recently23. An 
apicoplast-targeted, single-strand, DNA-binding protein 
that interacts with plDNA has also been identified24. 
Genes encoding putative apicoplast-targeted gyrase A 
and B have been located on Chr12 of P. falciparum, and 
gyrase B has been functionally characterized25,26. Cipro-
floxacin and novobiocin, that target bacterial DNA gyrase 
A and B subunits respectively specifically inhibit replica-
tion of P. falciparum plDNA and also reduce parasite 
growth in culture2,8,26. Ciprofloxacin has been shown to 
specifically increase the number of double-strand breaks 
in P. falciparum apicoplast DNA, but not affect nuclear 
DNA27. Plasmodium apicoplast DNA replication is thus a 
validated drug target. 
Protein synthesis in Plasmodium organelles 
The pathway of protein translation in Plasmodium organ-
elles, particularly the apicoplast, is of interest in the 
search for new drug targets. Most genes within the apico-
plast genome encode players involved in translation. 
These include 18 ribosomal proteins, large and small 
subunit rRNA, elongation factor Tu and a minimal set of 
25 tRNAs sufficient for successful synthesis of proteins 
within the compartment1. The parasite plastid is now 
known to be an active site for synthesis of proteins, evi-
dence for which was provided by the detection and  
organellar localization of apicoplast-encoded protein EF-
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Tu by Western blot and immunofluorescence28. Prior  
indirect evidences for apicoplast as a translation-
competent organelle were the detection of 70S ribosome-
like particles by electron microscopy29, and polysomes 
containing plastid-type rRNA and mRNA30. 
 Considering the endosymbiotic descent of the plastid, 
it is assumed that the mechanism and constituents of the 
process will be essentially prokaryotic. The apicoplast ri-
bosomal complex is predicted to include ~ 35 ribosomal 
proteins, all of which are not translated in the plastid. 
Sparing the 18 that are plastid-encoded, the rest are pre-
dicted to be nuclear-encoded and transported to the  
apicoplast. The tRNA repertoire in the apicoplast genome 
is sufficient for carrying the 20 amino acids needed for 
translation of proteins encoded by the organelle31, 
whereas the mitochondrial genome lacks any genes for 
tRNAs32. A significant fraction of the parasite proteome 
is dedicated to aminoacyl-tRNA synthetases (aaRSs), 
which catalyse the charging of tRNAs with the cognate 
amino acid33. Computational analyses have revealed that 
out of 37 aaRS encoded by the nuclear genome, 32% is 
apicoplast-targeted and 38% is cytosolic33. While very 
few Plasmodium aaRSs are predicted to be mitochondria-
targeted and there is also an indication of dual targeting 
of aaRSs between organelles in Plasmodium33, a study in 
T. gondii has revealed that aaRSs are altogether absent in 
mitochondria, thus suggesting that aminoacylated tRNAs 
are imported into the organelle34. 
 Apart from ribosomal particles and tRNA, mRNA 
translation depends upon vital protein translation factors 
that catalyse each step in the process providing kinetic 
stability to the intermediate complexes. Of these, except 
for elongation factor Tu, none is encoded by the plastid 
genome. Hence, it is obvious that the rest will have to be 
translocated from the cytosol to complement the resident 
translation machinery. The apicoplast elongation factor 
Tu is a 47 kDa protein belonging to the family of guanine 
nucleotide-binding proteins. EF-Tu mainly serves as a 
carrier for aminoacylated elongator-tRNAs during the 
elongation phase. Recombinant EF-Tu shows GTP hydro-
lysing activity and also an ancillary chaperone-related  
disulphide reductase function. Recently, another elongation 
factor, EF-Ts, necessary for the turnover of GTP on EF-
Tu for continuous elongation cycles, has been localized 
to the plastid using immunofluorescence of N-terminal 
GFP tagged leader peptide of Pf EF-Ts. The factor has 
also been demonstrated to interact with Pf EF-Tu to me-
diate GDP release from the latter, although the rate of this 
turnover is lower when compared to the bacterial system, 
which is understandable considering the less amount of 
translation needed in the organelle35. Interestingly, a mi-
tochondrial EF-Ts is not identified on the Plasmodium 
genome, suggesting that since only three genes need to be 
translated the mitochondria can do without a EF-Ts cata-
lysed turnover of the guanine nucleotide on EF-Tu35. 
Elongation factor EF-G that aids translocation of the pep-
tidyl tRNA from the ribosomal A site to the P site in pro-
karyotes is nuclear-encoded in Plasmodium species. 
Localization of two EF-Gs predicted to be targeted to the 
apicoplast and mitochondrion, has been confirmed by 
immunofluorescence analyses of parasites expressing  
C-terminal GFP and 3XHA tagged EF-Gs respectively36. 
 Although considerable attention has been directed  
towards elongation factors involved in apicoplast protein 
synthesis, the initiation and release factors targeted to the 
organelle have not been charaterized. Prokaryotic transla-
tion initiation involves the participation of three initiation 
factors IF1, IF2 and IF3 (ref. 37), all of which are pre-
dicted to be nuclear-encoded and transported to the api-
coplast in Plasmodium. In bacteria, IF3 is known as the 
anti-association factor as it binds at the contact point of 
50S and 30S ribosome subunits for keeping the ribosome 
in a split state38–40. It thus helps in maintaining the pool 
of free ribosome subunits for unhindered translation ini-
tiation via the 30S pre-initiation complex. IF1 is a small 
protein which mainly binds at the A site in the ribosome 
of the initiation complex and prevents premature binding 
of elongator tRNA41,42, but also shows 70S ribosome dis-
sociation activity38. While IF1 and IF3 are predominantly 
involved in ribosomal splitting, IF2, an essential GTPase, 
is responsible for recruitment of specific initiator tRNA to 
the mRNA start codon43. The apicoplast DNA contains a 
gene for the probable initiator Meti-tRNA which may be 
aminoacylated by N-formylmethionine and be carried by 
IF2 to the initiation complex in accordance to its pro-
karyotic counterpart. The aminoacylation and formylation 
reactions are thought to be catalysed by putative methio-
nyl-tRNA synthetase (MRS) and methinonine-tRNA for-
myltransferase (FMT) respectively, both of which are 
nuclear-encoded proteins and contain positive targeting 
signals for apicoplast compartmentalization44. A putative 
nuclear-encoded peptide deformylase (PDF) which  
removes formyl group from nascent polypeptides is also 
predicted to be apicoplast localized, indicating the use of 
formylmethionine as the initiating amino acid in api-
coplast-translated proteins44. Both FMT and PDF in 
Toxoplasma are targeted uniquely to the apicoplast and 
are absent from the mitochondria34. The absence of these 
enzymes in the mitochondria either means use of an  
unformylated initiator Met-tRNA, or a possible transport 
of formylated Met-tRNA from the plastid. 
 Terminitation of translation is supported by three  
release factors RF1, RF2 and RF3, in prokaryotes. In bac-
teria, class-I realease factors RF1 and RF2 recognize the 
stop codons UAA/UAG and UAA/UGA respectively45, 
and by mimicking aminoacylated elongator-tRNAs in the 
ribosomal A-site promote peptide chain release from the 
last elongator tRNA in the P-site45–47. UAA is the most 
commonly encountered stop codon in P. falciparum api-
coplast genes in the plasmoDB database. Class II-release 
factor RF3 is a GTPase which functions in recycling of 
RF1 or RF2, and their removal from the ribosomal A site 
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after hydrolysis of the peptidyl-tRNA bond48. While there 
are putative candidates for nuclear-encoded RF1 and RF2 
targeted to the plastid, a similar homologue for the RF3 
seems to be missing44. Various candidate genes that can 
serve as possible apicoplast and mitochondrial homo-
logues of bacterial translation initiation factors and  
release factors have been shortlisted after bioinformatic 
analyses of the Plasmodium genome database, as  
described in Jackson et al.44. 
Assembly of (Fe–S) complexes on apicoplast  
proteins 
Iron-sulphur (Fe–S) complexes assembled on target pro-
teins are known to play critical roles in electron transfer 
as well as redox and non-redox catalysis. They participate 
in important biological functions by serving as catalytic 
centres in electron transfer enzymes49,50. Fe ions in the 
complex are coordinated by cysteinates from the protein 
and are linked to each other through sulphide bridges. 
These clusters are found in all living organisms and are 
most commonly assembled as (2Fe–2S), (3Fe–4S) and 
(4Fe–4S). Three distinct operons, the nif, isc and suf  
operons, encode proteins required for (Fe–S) cluster  
biosynthesis in prokaryotes51–53. There is evidence that in 
bacteria, NIF (NifS, NifU required for maturation of the 
nitrogenase enzyme) and ISC (iron-sulphur cluster forma-
tion) are the housekeeping (Fe–S) assembly systems54, 
while SUF (sulphur mobilization, SufA, B, C, D, S, E) is 
adapted to assemble (Fe–S) clusters under environmental 
conditions such as iron starvation or oxidative stress55,56. 
The ISC system is present in bacteria and most eukarya, 
and the SUF system is found in archaea, bacteria, plants 
and protozoa. Plant chloroplasts use the SUF system for 
(Fe–S) biogenesis. 
 In general, several proteins act to assemble (Fe–S) 
clusters on target proteins. A cysteine desulphurase 
(NifS, IscS and SufS) is used by the three systems for the 
utilization of L-cysteine as a source of sulphur. A scaffold 
protein (NifU, NFU, IscU/ISU, IscA/ISA, SufU and 
SufA) then mobilizes sulphur atoms from a cysteine 
desulphurase and iron atoms from an iron donor to syn-
thesize an (Fe–S) cluster. Subsequently, the cluster is 
transferred to an apoprotein target to yield the holopro-
tein57. In addition to SufS, U and A, the SUF system is 
comprised of the SufB, C, D and E proteins. Three of 
these (SufBCD) form a tight complex58. SufC exhibits 
ATPase activity which is enhanced by SufB, as shown in 
Thermotoga maritima59,60. It has been proposed that the 
SufBCD complex may also function as the assembling 
centre for (Fe–S) clusters61. Bacterial SufE interacts with 
SufS, and the cysteine desulphurase activity of SufSE is 
stimulated by the SufBCD complex61,62. 
 The existence of a (Fe–S) cluster biogenesis pathway 
in both the apicoplast and mitochondria of P. falciparum 
has been proposed63,64, and several organellar proteins 
that participate in anabolic pathways are predicted to be 
modified by (Fe–S) prosthetic groups. Ferredoxin (Fd), 
IspG, IspH (involved in isoprenoid biosynthesis), LipA 
(lipoic acid synthase) and MiaB (tRNA methylthiotrans-
ferase) are apicoplast-targeted proteins which require 
(Fe–S) clusters; mitochondrial electron transport chain 
members such as the Rieske protein, a subunit of succi-
nate dehydrogenase, aconitase/IRP and class-I fumarate 
hydratase also require (Fe–S) assembly65,66. The (Fe–S) 
biogenesis pathway is likely to exist independently in the 
two organelles. Nuclear-encoded proteins of P. falcipa-
rum that exhibit homology to some ISC and SUF system 
components, which also carry predicted organelle target-
ing sequences have been identified63,67. The machinery 
for mitochondrial (Fe–S) cluster assembly includes  
homologs of the cysteine desulphurase NFS and scaffold 
proteins ISU and ISA68,69. Other mitochondrial proteins 
such as Fd and Fd reductase, chaperones Hsp70, DnaJ 
and GrpE may also be involved70. Proteins predicted to 
be involved in apicoplast (Fe–S) biogenesis are primarily 
of the SUF system. SufC, D, E and S are nuclear-encoded 
and a SufB analog (also called ORF470, Ycf24) is  
encoded by the apicoplast genome. The nuclear-encoded 
putative SUF components carry predicted N-terminal  
bipartite apicoplast targeting elements13. Only one scaf-
fold protein (NifU) exhibiting high homology with the 
cyanobacterium Synechocystis NifU is predicted to be 
apicoplast-targeted. 
 Recent biochemical characterization of the P. falcipa-
rum apicoplast-targeted SufC and its interaction with api-
coplast-encoded SufB has provided functional  
evidence for the existence of the SUF (Fe–S) complexa-
tion pathway in the apicoplast69. SufC exhibits ATPase 
activity and localizes to the organelle. The two recombi-
nant proteins interact in vitro and column-bound recom-
binant SufC co-elutes SufB from the P. falciparum lysate. 
Investigation of other components of the pathway is 
complicated by the difficulty of expressing functional re-
combinant proteins. The absence of the SUF pathway 
from the human host suggests the possibility of investi-
gating it as a target for antimalarial compounds5. How-
ever, the absence of any known inhibitors for Sufs makes 
it difficult to test the hypothesis pharmacologically and 
conditional knockout mutants would be required to con-
firm the essential nature of the (Fe–S) pathway in Plas-
modium. 
Apicoplast housekeeping pathways as targets for  
antimalarials 
Early studies revealing the requirement of a functional 
apicoplast for parasite survival used the fluoroquinolone 
ciprofloxacin, a selective-inhibitor of DNA gyrase A 
(Figure 1). Ciprofloxacin was shown to inhibit apicoplast 
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DNA replication in P. falciparum without affecting the 
replication of the parasite nuclear DNA2. The drug has 
been reported to cause parasite death both in the first in-
fection cycle as well as in a delayed-death manner71,72, 
and chemical derivatives of ciprofloxacin that enhance its 
antimalarial activity have been reported73. The coumerin 
drugs, coumermyin and novobiocin, inhibit GyrB and 
also exhibit anti-plasmodial activity. The intrinsic  
ATPase activity of the 45 kDa GyrB domain of P. vivax 
was shown to be sensitive to coumermycin, although at a 
higher Ki than reported for E. coli GyrB (ref. 74) and no-
vobiocin was shown to inhibit the ATPase activity of 
Pf GyrB with a Ki of 1.24 μM, a value ~ 3.5-fold higher 
than that reported for full-length E. coli GyrB 
(0.35 μM)26. Specific reduction in apicoplast/nuclear 
DNA ratios compared to mitochondrial/nuclear DNA  
ratios was observed upon novobiocin treatment in P. fal-
ciparum, indicating that the drug inhibited apicoplast 
DNA replication26. The elucidation of activity and struc-
tures of other DNA replication proteins such as the DNA 
polymerase subunit should aid in the identification of 
newer sites for drug design and intervention. 
 Transcription of apicoplast genes utilizes a eubacterial 
(α2ββ ′) system of DNA-dependent RNA polymerases 
that was inherited with the cyanobacterial endosymbiont75. 
The apicoplast genome encodes part of this system (β 
subunit by rpoB, and β ′ subunit by rpoC1 and rpoC2), 
while the remainder (α subunit, as well as sigma factor) 
are apparently encoded in the nucleus and targeted back 
to the apicoplast. The RNA polymerase of plastids is 
highly sensitive to rifampicin, and the in vitro and in vivo 
antimalarial activity of rifampicin suggests that the drug 
blocks apicoplast transcription76,77 (Figure 1). Trials with 
rifampicin in patients infected with P. vivax showed that 
although the drug, when given alone, cleared fever and 
reduced parasitaemia initially, it was not curative. 
 
 
 
 
Figure 1. Antimalarial checkpoints in housekeeping pathways of the 
Plasmodium apicoplast. 
Although all patients treated with the rifampin–
primaquine combination cleared both fever and parasi-
taemia, the therapeutic responses were slower than those 
following treatment with the chloroquine–primaquine 
combination76. Initial studies using a fixed combination 
of cotrimoxazole, rifampicin and isoniazid (Cotrifazid) 
had shown efficacy against resistant strains of P. falcipa-
rum in animal models and in small-scale human studies. 
However, a multicentric trial to test the safety and effi-
cacy of Cotrifazid concluded that the combination, in the 
formulation and regimen used, was not an attractive al-
ternative combination therapy for malaria78. 
 Antibiotics that target prokaryotic translation have 
been demonstrated to exhibit antimalarial activity (Figure 
1), although their inhibitory effect on parasitic growth is 
often slow. Despite this slow action, clinical studies have 
demonstrated good malaria cure rates with the translation 
inhibitors tetracycline and clindamycin when used in 
combination with a faster acting drug79,80, and doxycy-
cline is recommended by WHO as a prophylactic for 
travellers to endemic regions81. Investigations in T. 
gondii facilitated our understanding of antimalarial  
activities of these antibiotics and led to the observation of 
the ‘delayed-death’ phenomenon wherein the progeny of 
the parasite treated with the drug were more severely  
affected than the parasite itself2. Similar phenotypes were 
observed in P. falciparum treated with tetracycline, clin-
damycin and azithromycin71,72,82. These antibiotics  
affected the formation of functional merozoites in the 
second cycle, such that the abnormal merozoites were  
incapable of rupturing the host cell to establish fresh in-
fection83. 
 Translation inhibitory antibiotics act on different com-
ponents of the prokaryotic translation machinery. For  
instance, lincosamides (lincomycin and clindamycin) and 
macrolides (erythromycin and azithromycin) block pro-
tein synthesis by interacting with the peptidyl transferase 
domain of bacterial 23S rRNA. Clindamycin and 
chloramphenicol both act by blocking translocation of 
peptidyl-tRNAs and interfere with peptidyl transferase 
activity84. Tetracyclins interrupt translation by blocking 
the binding of the peptidyl-tRNA to the acceptor on the 
ribosomal small subunit85. Azithromycin has been shown 
to interact with domains IV and V of the 23S rRNA and 
the ribosomal proteins L4 and L22 (ref. 86). Thiostrepton 
and micrococcin also inhibit parasite growth. Thiostrep-
ton binds to 23S rRNA and inhibits the activity of EF-G 
by blocking Pi release after GTP hydrolysis. Thiostrepton 
has been reported to inhibit total P. falciparum protein 
synthesis at an IC50 that is greater than that for inhibition 
of parasite growth, suggesting that the principal target of 
the drug is different from cytoplasmic protein synthe-
sis87,88. The observation that the GTPase domain of the P. 
falciparum apicoplast LSU rRNA contains adenine  
nucleotide at two positions and is thus the likely target 
molecule for thiostrepton supported the apicoplast as the 
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primary site of action of the drug. Mitochondrial and nu-
clear LSU rRNAs have altered residues at one or both of 
these positions, and are thus unlikely to interact with the 
drug89. However, thiostrepton inhibits erythrocytic Plas-
modium growth in both the first and second cycles of in-
fection (countering the ‘delayed death’ phenomenon 
observed for apicoplast-specific drug action), and it has 
been recently suggested to additionally act on the parasite 
proteasome as well as affect the mitochondrion90,91. Anti-
biotics that interact with the translation factor EF-Tu 
(amythiamicin, GE2270A, and kirromycin) also exhibit 
antimalarial activity in blood culture92 and kirromycin  
affects apicoplast EF-Tu activity in vitro35. The steroid 
antibiotic fusidic acid targets EF-G and experiments in 
our laboratory have demonstrated the effect of this drug 
on apicoplast translation as well as interaction of api-
coplast EF-G with the ribosome (Gupta et al. unpublished 
results). In addition, ribosome-blocking antibiotics 
telithromycin and quinupristin-dalfopristin have also 
been shown to inhibit the growth of P. falciparum in a 
delayed-death manner93, suggesting their action on api-
coplast translation. 
 There is accumulating evidence that components of the 
apicoplast translation apparatus are the actual targets of 
antibiotics that exhibit antimalarial effects. Apicoplast-
specific effects such as disruption of protein import into 
the organelle by clindamycin and tetracycline71 and 
doxycycline-mediated block in expression of the  
apicoplast genome resulting in the distribution of non-
functional apicoplasts during erythrocytic schizogony83 
have been implicated in the antimalarial action of these 
drugs. 15-Deoxyspergualin that binds Hsp70 also shows 
apicoplast-specific inhibition leading to delayed death of 
parasites by blocking the import of nuclear-encoded pro-
teins into the plastid94. Azithromycin resistance generated 
in parasite lines has been attributed to a point mutation in 
the P. falciparum LSU rRNA as well as the apicoplast-
encoded ribosomal protein subunit82 Rpl4, and a point 
mutation in the LSU rRNA gene of the T. gondii api-
coplast has been shown to confer resistance to clindamy-
cin in vitro84. Live microscopy on Plasmodium berghei 
has shown that microbial translation inhibitors also block 
development of the apicoplast during liver-stage schizog-
ony and lead to impaired parasite maturation95. Identifica-
tion of additional targets in the organellar protein 
translation apparatus may offer new sites for drug inter-
vention and contribute to enhancing the drug repertoire 
against resistant strains. 
 Although the unique pathways and proteins of the api-
coplast offer opportunities for identification of novel drug 
targets, the evaluation of the precise target-specific  
activities of lead compounds remains a challenge. For  
instance, it is possible that inhibitors believed to target 
the apicoplast translation process may also have off-
targets at other locations in the parasite, including the 
other organelle of prokaryotic origin – the mitochondrion. 
A very recent development that will aid in confirming the 
apicoplast as the site of action of specific antimalarials is 
the chemical rescue of apicoplast minus P. falciparum 
parasites in asexual blood stages by isopentenyl pyro-
phosphate (IPP), which is the product of the non-
mevalonate isoprenoid biosynthesis in the apicoplast95. 
Maintaining IPP supply seems to be the only essential 
function of the relic plastid. Thus, apicoplast-specific  
action of an active compound can be assayed by rescue of 
the treated blood-stage parasites on supplementation with 
IPP96. In addition, attention should also be focused on the 
role of the apicoplast in the liver stages of the parasite 
cycle, where its metabolic activities may be different 
from those in the blood stages. 
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